In the course of blood tests on patients attending a rheumatism clinic it was noticed that the serum was often pale green rather than the normal yellow colour. We have found only one reference to this phenomenon, by the late Dr J Bodman who stated (1960) that 'Sera from advanced malignancies and rheumatoid arthritis often show a greenish tinge.... ' We also noted that in addition to the difference in colour, the green sera all appeared paler than normal.
Subjects Studied
To assess the incidence of this finding, serum was collected from 87 unselected patients under the care of a rheumatism unit. Samples were arbitrarily classified into three groups, typical pale green, normal, and intermediate. This last group contained all gradations between the two extremes.
Of the 60 patients with classical or definite rheumatoid arthritis (American Rheumatism Association's classification'), 32 had typical pale green serum. Of the remaining 27 patients who had a variety of other diagnoses, typical pale green serum was seen only in 2 cases of osteoarthritis. Multiple samples were taken from many patients with both yellow and green serum, and in no case did the appearance subsequently differ.
Serum was also examined from 50 other subjects, including hospital patients with nonrheumatic diseases and normal controls. Typical green serum was found in only one case of cirrhosis of the liver and one case of reticulum cell sarcoma. Pale serum with a greenish tinge, but without the typical colour, was also seen in samples from 4 patients with hypochromic anemia. 'Ropes et al. 1956 'Ropes et al. , 1958 Studies ofSerum Careful enquiry showed that there was no form of medication which was common to all the patients with green serum.
Bacteriological examination excluded the presence of chromobacteria in specimens of green serum.
Electrophoresis of samples of green serum showed only the well-known protein changes of rheumatoid arthritis, consisting of a slight increase in the a2-and y-globulin, and these changes in no way differed from those found in control subjects with rheumatoid arthritis whose serum was of normal colour.
In an attempt to characterize the differences objectively, the absorption spectra of normal and typical green serum were compared. To avoid difficulties in interpretation due to turbidity, these measurements were confined to specimens which were crystal clear to the naked eye. In Fig 1 the absorption spectrum of a typical yellow serum is contrasted with that of a typical green serum over approximately the visible range. It can be seen that the area under the curve for the yellow serum is considerably greater than that for the green serum, suggesting that the former is more deeply coloured. Furthermore, the curve for the Although present, these are both much less conspicuous in the green serum. These differences were found to correlate consistently with the naked-eye appearances of the serum. Since all the curves were of the same general shape it was felt that the area under the entire visual spectrum could be used as an arbitrary index of the depth of colour in the serum. Fig 2 shows that the areas under the curves for serum of normal colour were consistently greater than those for green serum, corresponding with the visual impression that the green serum is paler than normal.
As an index of the extent of the peaks in the blue portion of the spectrum, at 460 and 480 mV, the area under this portion of the curve was measured and expressed as a proportion of the area under the whole curve. In serum, bilirubin, iron and carotene contribute to the absorption at 460 m,±. While these were always within normal limits in samples of green serum, they tended to be rather lower than in yellow sera and differences in the concentrations of these substances may, therefore, explain at least some of the differences in absorption at this wavelength.
The difference in absorption at 480 m,> could not be related to any clinically important substances.
Further characterization of the difference between green and yellow sera was attempted by deproteinization with acetic acid and extraction with ether, using a modification of Fischer's (1936) technique. In Fig 4 are shown the typical absorption spectra of extracts from green and yellow samples. Extracts of yellow serum from normal subjects gave exactly similar patterns to those of yellow serum from patients with rheumatoid arthritis. The extract from green serum shows a peak at approximately 362 m,I and a diminution in the peaks at approximately 405 and 450 mV±. In some rheumatoid subjects an extra peak at 303 mV± was found to correlate with salicylate therapy and the occurrence of this peak was confirmed in normal subjects after the ingestion of salicylates. The diminished peak at 450 m,u may be due to a lower concentration of bilirubin in the green serum, since this wavelength is approximately where free bilirubin has its absorption maximum. The diminished peak at 405 m,u may be due to a difference in concentration of one of the porphyrin derivatives, which have absorption peaks in this region. The peak at 362 m,u was found in the extracts from most Since there is no absorption peak at 392 ml± in the extracts of green serum it appears likely that the green colour was not due to biliverdin, or to the green pigment choleglobin, which would have been converted to biliverdin by the extraction procedure.
A similar extraction was performed on the greenish tinged, pale serum of hypochromic anemia. This showed no peak at 362 m, but instead there was an absorption peak at 392 mtu, suggesting that in this case the colour of the serum was due to biliverdin or choleglobin.
It thus appeared that the absorption peak at 362 mF might represent an unusual constituent of the serum in some patients with rheumatoid :arthritis whose serum had an abnormal appearance, and further studies are in progress to attempt to characterize this substance.
